CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.6, ss.1139-1147, 2014 (SCI-Expanded)
This phase II trial aimed to evaluate the efficacy and safety of docetaxel, cisplatin, and fluorouracil (DCF) combination in neoadjuvant setting in patients with locally advanced gastric adenocarcinoma.